At JY Medtech, we're at the forefront of peptide technology, pioneering advancements in the research, development, and production of peptides, peptidomimetics, and related high-activity compounds. With a team of over 500 dedicated professionals, including a core team with two decades of industry experience, we're redefining standards in peptide CDMO services. Our multidisciplinary approach spans pharmaceutical chemistry, organic chemistry, analytical chemistry, bioengineering, and more, ensuring a comprehensive solution for our clients. As VP, I'm committed to fostering strategic partnerships in the Americas, Europe, and ASEAN regions, bringing our cutting-edge peptide solutions to a global stage. Join us as we continue to push the boundaries in peptide therapeutics, from laboratory research to industrial-scale production.

AmbioPharm is a global peptide CDMO founded in 2005 and headquartered in North Augusta, South Carolina, USA specializing in developing highly efficient manufacturing processes for peptide-based Active Pharmaceutical Ingredients (APIs) at very small to very large scales. In our manufacturing facilities in South Carolina, USA and Shanghai, China, we manufacture New Chemical Entities (NCEs) and generic peptide APIs under cGMP for clients worldwide. Both facilities have been inspected multiple times by the FDA with excellent outcomes.

Currently driving the commercialization of a first-in-class line of supplements while navigating a complex regulatory environment in the U.S. market; shaping the long-term business development strategy at this startup; steering product marketing as per FDA regulations in collaboration with regulatory and legal consultants.• Anticipating $11M sales in the first year, compared to the $900K original forecasted sales, after optimizing price point and shifting target audience; won executive buy-in after presenting a business case based on an analogous product. • Secured Letters Of Interest (LOI) from investors after strategizing Series A financing; led outreach to healthcare and biotechnology companies; offered to create products that catered to consumer needs.• Improved brand visibility by engaging large purchasers, medical conferences, and patient support groups; leveraged a network of Active Pharmaceutical Ingredient (API) manufacturers and drug developers, including a Fortune 500 firm.• Achieved highly positive reception after initiating pre-sale; identified thought leaders, including gastroenterologists; pinpointed and utilized best-fit sales channels.

Spearheaded end-to-end business development and commercialization for first-to-market products; directed and mentored a growing sales and ops team. Grew the product line to fulfill unmet market needs; conceived innovative product concepts in partnership with scientific teams; steered product development, approval, and distribution.Bottom-Line Growth & Client Retention• Scaled sales of a first-of-its-kind product to 1,000 units/month from scratch by strategically lowering price by 71% while maintaining the 87% margin.• Played a pivotal role in conceiving and commercializing 8 synthetic and natural supplement products, mostly first-in-class products.• Attained multi-year retention of strategic clients in an increasingly competitive space; maintained above-average client retention rates; nurtured trust-based relationships and educated customers on false advertising. • Reduced API supply cost by 80% by sourcing cost-effective manufacturers that met quality standards and GMP guidelines; toured factories worldwide; conducted online research on 100+ API manufacturers. Sales Infrastructure Development, Strategic Planning, & Risk Mitigation• Founded core sales infrastructure; instituted frameworks for account management, prospecting, and sales follow-ups; built the customer service and business development teams; cultivated a results-driven culture by creating sales contests and incentives. • Identified mission-critical regulatory issues in the core business model; relaunched the company as a supplement company with a high-margin product; partnered with regulatory and legal teams as well as senior leadership. • Won the buy-in of manufacturers for incremental payment plans while negotiating supply contracts worth up to $500K. • Mitigated risks to on-time product demand fulfillment by fostering relationships with alternative suppliers, testing companies, and payment processors; paved the way to meet a sudden demand hike at the onset of the pandemic.

Revitalized an underperforming territory in a saturated market; researched and uncovered lucrative sales opportunities; performed prospecting and cold calling; secured sales meetings; utilized Salesforce CRM; collaborated with the medical affairs team.• Tasked by the Head of Sales to coach 44 territory managers across the West Coast on unique and proven sales methodologies.• Earned the President's Club award in both years of employment, ranking among the top 10% of the workforce.

• Elevated territory from the second-lowest rank to #3 out of 223 territories nationwide; developed and leveraged technical product knowledge to educate physicians; ranked among the top 2% of sales specialists nationwide. • Secured the "Pinnacle of Success Prize” that was awarded to 44 employees out of 35,000; won the President’s Club award.

• Elevated territory from the lowest rank nationwide to #1 within 2 quarters by driving sales to immigrant communities that used prescription pancreatic enzymes; built and drew on expertise in the Korean, Japanese, and Chinese cultures. • Increased call volume by 45% by geocoding and mapping a sales territory; selected to onboard 80 peers throughout the U.S. on an early version of an intelligent route mapping software.

•As part of two man team, worked as a consultant for educational expansion initiative of President Alvaro Uribe's foundation Primero Colombia•Conducted expert interviews; collected data; ran statistical analyses; produced report that serves as blueprint for the goal of providing higher education to all Colombians

• Assisted in the collection, indexing, and cross checking of private source intelligence in AMISOM's Mission Analysis Cell,• Cultivated and sustained relationships between the AU and donors, and helped organize a conference to coordinate the pledging activities of the forty donor countries from the June 2009 Brussels/Somalia donors conference.

• Worked to improve the relationship between the UN and the African Union. • Wrote and edited SOWs and MOUs for services to be outsourced (e.g., setting up a Somali language radio network in Mogadishu to deliver news and entertainment to Mogadishu’s citizens for public relations purposes).

• Helped launch a public health campaign to raise awareness about the importance of preventing exposure to solvents used in the construction of furniture that was found to cause a large spike in birth defects in a manufacturing cluster of Ecuador.

• Collected clinical data and assisted in cadaver tissue collection. • Researched comparative case studies, cataloged tissue samples, systematized data, and analyzed findings. Second author listed on "Adipose Tissue in Myocardial Infarction," Cardiovascular Pathology, 13: 98-102.